GABA and glycine are the major inhibitory neurotransmitters in the mammalian CNS. GABA-mediated inhibition is found throughout the neuraxis but is most prominent in rostra1 brain areas. On the other hand, glycine mediated inhibition appears to be limited to posterior brain regions (Aprison and Nadi, 1977) . A greater understanding of the distribution of GABA and glycine neurotransmitter function and the relationship between GABA and glycine-mediated inhibition would clarify the regional specificity of inhibition mediated by these 2 neurotransmitters and further define their functional interrelationships. In this paper we present data on the distribution of inhibitory postsynaptic glycine receptors in the mouse CNS.
The anatomical localization of neurotransmitter receptors provides detailed information on the distribution of the postsynaptic response potential of different regions to neurotransmitter activation. Combined with similar data on presynaptic function, this information defines the functional anatomy of neurotransmitter systems and thus is an important aspect of the biochemical anatomy of the nervous system. Receptor localization in experimental material increases our understanding of the consequences of manipulations; similar studies on pathological material may shed light on the causes and consequences of disease states (Whitehouse, 1985; Palacios et al., 1986) .
Studies on the localization of neurotransmitter receptors have been greatly facilitated by the development of specific binding assays for slide-mounted tissue sections combined with reliable diffusable substance autoradiographic techniques (Young and Kuhar, 1979; Kuhar, 1985) . Numerous studies employing these techniques have defined the anatomical localization of most known neurotransmitter receptors in a variety of mammalian and nonmammalian species (Kuhar, 1985; Kuhar et al., 1986; Palacios et al., 1986) . The application of computer-assisted analysis methodologies has greatly facilitated the quantification and interpretation of autoradiographic data (Goochee et al., 1980; Palacios et al., 198 1; Altar et al., 1984; Hibbard and Hawkins, 1984; Stein et al., 1984; Davis et al., 1986; Zilles et al., 1986) .
There are 2 significant limitations with current methodologies for receptor quantitation. The first is differential efficiency of tritiated ligands in exposing silver grains depending on the tissue localization of the ligand (Alexander et al., 1981; Herkenham and Sokoloff, 1984; Kuhar and Unnerstall, 1985) . The second is inadequate quantitation of receptor-specific activity in individual sections through 3-dimensional morphological regions. In this paper we address these limitations using computer methodologies and present the quench corrected 3-dimensional distribution of glycine receptors in the mouse central nervous system using 3H-strychnine as the ligand.
The data presented in this paper are from one representative animal. The same qualitative results were seen for all the animals.
The methods for 'H-strychnine binding to slide-mounted tissue sections were similar to those reported for rat CNS (Zarbin et al., 1981) with several modifications that facilitated cutting the brain, improved specific binding, and decreased nonspecific binding. Mice were perfused intracardially with 250 ml of fixative solution consisting of 0.1% paraformaldehyde, 100 mM NaCl, 320 mM sucrose, 50 mM sodium phosphate buffer (pH 7.4), followed by 50 ml of the same solution without the paraformaldehyde.
The brain and spinal cord to the cervical spinal cord level of C3 were rapidly removed and frozen onto a cryostat chuck with O.C.T. compound (Miles Scientific). Serial lo-wrn sections were cut on a cryostat, mounted on gelatin-coated microscope slides, air-dried, and stored desiccated for up to 2 months at -20°C prior to use. Storage did not alter the results.
Sections separated by approximately 120 pm were preincubated for 1 hr in 100 mM NaCl, 50 mM sodium phosphate buffer (pH 7.4) to remove endogenous ligands, incubated 1 hr in 5 nM 'H-strychnine in this buffer to label receptors, washed in 4 changes of fresh buffer for a total of 1 min to reduce nonspecific binding, dipped in distilled water to prevent salt crystal formation, and rapidly dried with anhydrous air to trap the ligand on or near the receptor. Adjacent sections were incubated in buffer containing 'H-strychnine and 10 mM glycine to determine nonspecific binding. Autoradiograms were prepared by exposing the sections to LKB Ultrofilm-3H for 4 weeks. Films were developed in Kodak D-19 for 5 min, stopped in H,O for 15 set, fixed in Kodak Rapid Fix for 5 min, and washed in H,O for 1 hr, all at 19°C.
Differential efficiency was determined using the method of Herkenham and Sokoloff (1984) . Following exposure, the same sections used for 3H-strychnine binding studies were preincubated at room temperature in 3 changes of 100 mM NaCl, 5d mr.,r Tris-HCl buffer (pH 7.2) at 22°C for a total of 4 hr. This resulted in comnlete dissociation of bound 'H-strychnine as shown in parallel experiments. Sections were then incubated in 4 nM )H-succinimidyl propionate at 22°C for 30 min, followed by a IO-min wash in 4 changes of fresh buffer and 10 set in distilled water. The sections were exposed to Ultrofilm-zH for 10 d. Lipids were removed from a series of sections labeled with 3H-succinimidyl propionate by first dehydrating in ascending alcohol concentrations, followed by 1 hr in xylene, and rehydrating in descending concentrations ofalcohol (Herkenham and Sokoloff, 1984) . The sections were then reexposed to Ultrofilm-3H for 10 d. Adjacent sections were processed identically following incubation with 0.06 nM 1251-Bolton and Hunter reagent to assess the labeling with a compound that has the same binding characteristics as succinimidyl propionate but does not show differential efficiency. Following exposure to the film, the sections were stained with cresyl violet for anatomical analyses.
Quantitative analyses were performed using software developed on a VAX 1 l-780 computer in the Image Graphics Iaboratorv at Children's Hospital, Boston. The density of exposed silver grains was digitized on an Optronics P-1000 scanning drum densitometer at a resolution of 50 pm. The average optical density of the film surrounding the exposed autoradiograms was subtracted from the optical density values of each pixel within the autoradiograms to correct for film background. Optical density was converted to specific activity using a cubic fit to the relationship between optical density (following the subtraction of film background) and specific activity from a step wedge standard (Amersham) and rat whole brain paste standards exposed with the experimental material. Following conversion to specific activity, each image was registered with an image from an adjacent section that had been processed for nonspecific binding and the nonspecific binding values were subtracted pixel by pixel. Receptor distribution maps were smoothed by a nearest-neighbor averaging routine to produce images with greater spatial contiguity. The smoothing algorithm employed was 2 pixels deep and weighted by the inverse square law. This algorithm was chosen because it produced adequate spatial contiguity of the autoradiographic distribution and maintained the spatial distribution of the image. The smoothed receptor distribution maps were used to draw isodensity contours which circumscribe areas of equivalent binding used in the registration and 3-dimensional display of the data. Additional filtering of the isodensity contours was performed to reduce the complexity of the resulting image. This was accomplished using a 4-point spline routine. Graphic images were displayed and registered on a Megatek 7295 3-D color raster display monitor. Photographs were taken either directly from the Megatek screen or with a Dunn camera.
The boundaries of anatomical nuclei were digitized from camera lucida drawings of the stained sections using a bitpad. Anatomical boundaries were determined according to Sidman et al. (197 l) , and Paxinos and Watson (1986) . Registration with receptor distribution data was performed using algorithms developed for the raster display monitor. Nuclear boundary contours were compared with receptor distribution data and, if warranted, modified where there were obvious discrepancies. Conservative estimates of nuclear boundaries were used where ambiguities existed.
Materials Figure 1 Figure 2E is the distribution displayed as specific activity following the subtraction of film background.
Nonspecific binding determined on adjacent sections incubated with 3H-strychnine and 10 mM glycine was indistinguishable from film background; therefore, no further correction was required for nonspecific binding. Figure 2F is the distribution displayed as specific activity following nearestneighbor smoothing to produce an image with greater spatial contiguity.
At this level of the mouse brain stem, high levels of 3H-strychnine binding sites were observed in the hypoglossal nucleus and the nucleus of the spinal tract of 5; no specific binding was seen in the cerebellum. Ligands used for the localization of neurotransmitter receptors often are labeled with tritium because of the ease of labeling and purification, the high specific activity obtained, the stability, and the pharmacological similarity of the labeled compound to the parent compound (Bennett and Yamamura, 1985) . The low energy of the beta emission produced by tritium has both advantages and disadvantages.
The major advantage is that the path length is short, which results in a high degree of spatial resolution within the tissue section (Rogers, 1979) . It also makes it possible to cut relatively thin sections that are infinitely thick in relation to path length; thus minor variations in section thickness do not produce variations in perceived receptor density (Falk and King, 1963; Caviness and Barkley, 197 1; Alexander et al., 198 1) . The major disadvantage is the differential efficiency of bound tritiated ligands in exposing silver grains depending on the localization of the ligand in the tissue (Alexander et al., 198 1; Herkenham and Sokoloff, 1984; Kuhar and Unnerstall, 1985) . The lipid content of the tissue contributes to the differential efficiency because the efficiency is lowest in areas of high lipid content, such as myelinated fiber W pathways, and delipidating the tissue with organic solvents removes differential efficiency (Herkenham and Sokoloff, 1984; . Although procedures have been developed for removing differential efficiency by removing lipids in localization studies for several neurotransmitter receptors (Herkenham and Pert, 1982) , this is not applicable to ligands for many receptors where the delipidating procedure also removes the bound ligand (Kuhar and Unnerstall, 1982) . A general method for correcting differential efficiency using computer methodologies was developed. This method relies on the uniform binding of 3H-succinimidyl propionate to CNS tissue sections. The uniform labeling by 3H-succinimidyl propionate has been shown by the uniform optical density of )Hsuccinimidyl propionate-labeled sections following lipid removal and the uniform autoradiographic density obtained from tissue sections labeled with lZSI-Bolton and Hunter reagent (Herkenham and Sokoloff, 1984 ; and this study, data not shown); 'H-succinimidyl propionate is a tritiated analog of 'Z51-Bolton and Hunter reagent and lz51 is not differentially quenched by tissue constituents.
The Ultrofilm-3H autoradiogram for )H-succinimidyl propionate binding to the mouse brain section shown in Figure  1 A is shown in Figure 1 C. The top row of Figure 2 shows the color-coded, digitized distribution of (A) optical density, (B) specific activity, and (C) smoothed specific activity of 3H-~~~-cinimidyl propionate binding to the same section shown for 3H-strychnine binding in the middle row. Because )H-succinimidyl propionate binds uniformly to the tissue section, the differences in optical density and specific activity observed in these images resulted from differential efficiency due to tissue localization. The relative efficiency of the 3H-succinimidyl propionate images was determined by comparing the specific activity of the images before and after delipidation. From these images it is apparent that the efficiency in the granule cell layers of the cerebellum and in dorsal nuclei of the brain stem was high (85 + 11%) and the efficiency in the white-matter areas of both cerebellum and brain stem was low (39 f 6%). There were isolated pixels with efficiencies as high as 97% and as low as 20%.
To correct for differential efficiency, the data for 3H-strychnine binding were registered with the data for 3H-succinimidyl propionate binding, and the 3H-strychnine specific activity was divided by the relative efficiency of 3H-succinimidyl propionate binding, pixel by pixel. This procedure resulted in the correction for differential efficiency of specific activity values for 3H-strychnine binding as illustrated for both unsmoothed and smoothed 3H-strychnine binding site distributions in Figure 2 , G, H.
Although correcting for differential efficiency in this region of the mouse CNS did not change the areas of maximum binding, t it did alter the relationship of binding between areas. This method for correcting differential efficiency should be generally applicable for tritium-generated autoradiograms. If the ligand cannot be dissociated completely from the section, then adjacent sections can be used for labeling with ligand and 3H-succinimidyl propionate.
The quantification of receptor density in specific anatomical nuclei is typically performed by determining receptor density within the boundaries of anatomical nuclei from one or several sections taken through the nucleus and not from sections taken through the full extent of the nucleus. Similarly, frequently the quantification does not include the entire nucleus on a single section, but rather the area of greatest density or the center of the nucleus. Both of these practices bias quantification to the density found in small regions through the nucleus; they do not take into consideration the density throughout the nucleus. These problems can be solved by looking at the 3-dimensional distributions of receptors through anatomical regions and by demarcating nuclear boundaries from the morphological features of the section used to generate the autoradiograms.
The 3-dimensional distribution of quench-corrected 3H-strychnine binding sites can be determined when the above procedures are carried out using serial sections through a single mouse brain and the information from adjacent sections is registered. Both the registration and viewing can be greatly improved by first converting the data from solid display format to isodensity contours that circumscribe regions of equivalent binding density. This is best accomplished using the data that have been smoothed. Isodensity contours for 3H-succinimidyl propionate binding are shown in Figure 3A and for )H-strychnine binding in Figure 3C . The isodensity contour localization of 3H-strychnine binding sites in relation to the outer limits of the tissue section is shown in Figure 3B . The image was generated by registering the isodensity contours for 3H-strychnine binding to display the distribution of binding with the outermost isodensity contour from the 3H-succinimidyl propionate binding which outlines the tissue section.
The 3-dimensional distribution of quench corrected )Hstrychnine binding sites in the mouse brain as seen from 13 different angles is shown in Figure 4 . In all 3-dimensional images the z-axis has been expanded 3-fold and a hidden-line algorithm has been performed to aid in viewing. A very low level of binding, 40 fmol/mg, is shown in Figure 4A ; areas lying within the displayed contours contained 3H-strychnine binding sites, while areas not lying within the contours did not contain 3H-strychnine binding sites. A moderate level of binding, 320 fmol/mg, is shown in Figure 4B , and a high level of binding, 560 fmoV mg is shown in Figure 4C .
The 3-dimensional, quench-corrected distribution of )H- Figure 2 . Digitized, color-coded, and further processed images of the autoradiograms shown in Figure 1 . The digitized, color-coded optical density ofthe distribution of relative quench measured by the binding of 'H-succinimidyl propionate is shown in A. The distribution of the specific activity of 'H-succinimidyl propionate binding determined by background subtraction and conversion to specific activity using a step-wedge standard is shown in B; and the smoothed specific activity distribution accomplished using a nearest neighbor smoothing algorithm is shown in C. The middle row contains the same information on the distribution of glycine receptors measured by 3H-strychnine binding. Thus, D is the distribution of glycine receptors in optical density, E is the distribution in specific activity, and Fis the smoothed specific activity. The quench-corrected distribution of glycine receptor specific activity and smoothed specific activity is shown in G and H. Quench is corrected by registering and then dividing the information on receptor distribution with the information on quench distribution, pixel by pixel, and multiplying the result by a factor that corrects for minimum quench and the relative efficiency between 'H-succinimidyl propionate binding and the step-wedge standards as described in the text. The color code contains 15 colors; maximum binding is displayed as red, followed by pink, orange, yellow, greens, blues, purples, and grays. The same color table relating color to value is used for images A and D, for images B and C, and for images E-H. We have attempted to maintain the same relationship between the different color tables and the relative magnitude of the data. , and 560 fmoVmg (C), viewed from 13 different angles. Isodensity contours of quench-corrected glycine receptor distribution and the lowest level of quench distribution to provide an outline of the brain from serial sections taken from C-3 to frontal pole were registered into 3-dimensional maps of receptor distribution. The sections were separated by an average of 120 pm; in all 3-dimensional images the z-axis has been expanded 3 times to facilitate viewing. The outlines of the sections are shown in gray; the isodensity contours for glycine receptor distribution are shown in white.
strychnine binding sites seen from a dorsal posterior viewing angle is shown in Figure 5A ; each successive image is the 3-dimensional distribution of 3H-strychnine binding sites at 40 fmol/mg higher levels of binding. Thus, the first image is the outline of areas containing greater than 40 fmol/mg, the second image is the outline for greater than 80 fmol/mg, and the last is the outline of binding greater than 600 fmol/mg. Figure 5B is the distribution of 3H-strychnine binding sites viewed from a ventral anterior vantage. Fifteen levels of binding are shown ranging from greater than 40 to greater than 600 fmoYmg. The receptor distribution information can also be registered with information on the boundaries of anatomical features of the tissue section as shown for the section illustrated in Figures  l-3 in Figure 6 . It is then possible to extract the binding data based on anatomical location in a 3-dimensional fashion. This is done by determining the average density for the anatomical Table 1 .
The value of analyzing receptor distribution data in this fashion is shown in Figures 7 and 8 . Figure 7 illustrates the sectionby-section binding of -'H-strychnine to 3 nuclear groups: (A) the hypoglossal and prepositus hypoglossal nuclear group, (B) the substantia gelatinosa of the spinal cord and trigeminal nerve nuclear group, and(C) the medullary reticular formation nuclear group. The relative distribution of binding in each nuclear group was distinct, but the difference in binding seen between different sections illustrates an anterior-posterior heterogeneity in 'Hstrychnine binding. A similar heterogeneity for all the pixel values contained within nuclear boundaries is illustrated in Figure 8 for the (A) hypoglossal nucleus, (B) cuneate nucleus, and (C) ventral cochlear nucleus. From these examples it is apparent that it is important to sample as much of a nucleus as possible to determine the most accurate density of neurotransmitter receptor. Furthermore, these types of analyses make it possible to study the heterogeneity in terms of anatomical, functional, and other subdivisions within defined nuclei, as well as poten- The highest levels ofbinding were seen in motor areas. Ventral layers of the spinal cord and the hypoglossal nucleus that innervate striated muscles had very high levels of 3H-strychnine binding. Binding in Ro was about 30% that seen in 12. (See footnote to Table 1 for definitions of abbreviations.) Branchial efferent nuclei Amb, 7, P7, and Mo5 had moderate to high levels of binding; they contained very high levels of binding for nuclei at their more rostra1 locations. Nucfei involved in eye movements, 4,6, and Dk had much lower binding than other motor areas. Moderate levels of binding were seen in autonomic motor area 10 and EW and AP had very low levels of binding. Binding in SNR of the extrapyramidal motor system was low to moderate but the highest of nuclei in the midbrain. There was a pronounced medial-ventral to dorsal-lateral gradient within SNR with more dorsal-lateral areas containing little binding; thus, medial-ventral areas within SNR have much higher binding than indicated by the mean. Binding in the SNC was about t/3 that seen in SNR.
The substantia gelatinosa of the spinal cord and its rostra1 extension into SpSC, I, 0, and Pr5 had very high levels of caudal levels; the associated GrC and ECU contained only about binding. There is a definite caudal-rostra1 gradient in this bind-'/3 the number of sites seen in Gr and Cu. The thalamic relay ing with cervical cord containing almost 3 times the number of nuclei VPM and VPL contained no specific binding. binding sites as rostra1 sections of Sp50 and Pr5. Levels in Me5
The nuclei of the special sensory afferents relaying auditory were about l/3 that seen in Sp50 and Pr5. Binding in the nuclei and vestibular information had lower binding than those inof the dorsal columns, Gr, and Cu was moderate, slightly higher volved in somatosensory function. Highest binding in the cothan '/z that seen in the substantia gelatinosa at the same rostralchlear nuclei was found in DC, with about Y3 as many sites in Figure 5 . Continued VC and Y3 as many in VCP. In associated nuclei, the LSO had levels equivalent to DC, and the MS0 had only about Y2 the density of sites; the DLL and VLL were intermediate and TZ was much lower, with about 15% as many binding sites. The MVe was highest among the primary vestibular nuclei, being equal to the DC and LSO; SpVe had about 3/4, LVe about %, and SuVe about '/4 the number of binding sites. The CeC, which gives rise to spinovestibular projections, had almost 2'/2 times the density of sites as MVe. The associated PrH had about 30% more sites than MVe and X has about '/z the sites seen in MVe. The thalamic nuclei of the auditory system, MGD and MGV, had very low to no specific binding sites. Binding in Sol, which receives autonomic afferents, had a moderate level of binding, comparable to that seen in MVe and DC, PSol had only about '/z the level of binding. Levels similar to PSol were seen in LPB and MPB and levels 50% greater than Sol in LPBI and 75% less are seen in the related PBG and KF.
The distribution of 3H-strychnine binding sites in the reticular The anatomical boundaries of nuclei and fiber pathways were digitized from camera lucida drawings made from the tissue sections stained with cresyl violet after autoradiography. The digitized boundary contours were registered with the receptor distribution data and used to define pixels localized to specific anatomical areas. The number of sections in which the region is found, the total number of pixels in the region, the mean of the quench-corrected specific activity values in those pixels, and the standard deviation are presented. Abbreviations are those used by Paxinos and Watson (1986) : 4, trochlear nucleus; 6, abducens nucleus; 7, facial nucleus; 10, dorsal motor nucleus of the vagus; 12, hypoglossal nucleus; Amb, ambiguus nucleus; Amyg, amygdala; AP, area postrema; APT, anterior pretectal nucleus; Aq, aqueduct (Sylvius); Arc, arcuate nucleus; bit, brachium of the inferior colliculus; cc, central canal; CeC, central cervical nucleus; CG, central gray; CGPn, central gray of the pons; CIC, central nucleus of the inferior colliculus; tic, commissure of the inferior colliculus; CL, centrolateral thalamic nucleus; CM, central medial thalamic nucleus; CnF, cuneiform nucleus; cp, cerebral peduncle, basal part; Cu, cuneate nucleus; cu, cuneate fasciculus; DA, dorsal hypothalamic area; DC, dorsal cochlear nucleus; DCIC, dorsal cortex of the inferior colliculus; Dk, nucleus of Darkschewitsch, DLG, dorsal lateral geniculate nucleus; DLL, dorsal nucleus of the lateral lemniscus; DM, dorsomedial hypothalamic nucleus; DpG, deep gray layer of the superior colliculus; DPGi, dorsal paragigantocellular nucleus; DpMe, deep mesencephalic nucleus; DR, dorsal raphe nucleus; DTg, dorsal tegmental nucleus; ECIC, external cortex of the inferior colliculus; ECU, external cuneate nucleus; EW, Edinger-Westphal nucleus; FF, fields of Forel; fr, fasciculus retroflexus; G, gelatinosis thalamic nucleus; Gi, gigantocellular reticular nucleus; GiV, gigantocellular reticular nucleus, ventral part; Gr, gracile nucleus; GrC, granular layer of the cochlear nuclei; IS, intertrigeminal nucleus; icp, inferior cerebellar peduncle (restiform body); IMLF, interstitial nucleus of the medial longitudinal fasciculus; InCo, intercollicular nucleus; Int, interposed cerebellar nucleus; IO, inferior olive; IP, interpeduncular nucleus; IRt, intermediate reticular nucleus; KF, Kolliker-Fuse nucleus; Ll, layer 1 of the spinal cord, L23, layer 2 and 3 of the spinal cord, L45, layer 4 and 5 of the spinal cord; L6, layer 6 of the spinal cord, L7, layer 7 of the spinal cord, L89, layer 8 and 9 of the spinal cord, LlO, layer 10 of the spinal cord, Lat, lateral (dentate) cerebellar nucleus; LC, locus coeruleus; LD, laterodorsal thalamic nucleus; LDTg, laterodorsal tegmental nucleus; LH, lateral hypothalamic area; LHb, lateral habenular nucleus; Li, linear nucleus of the medulla; 11, lateral lemniscus; LM, lateral mammillary nucleus; LP, lateral posterior thalamic nucleus; LPB, lateral parabrachial nucleus; LPBI, lateral parabrachial nucleus, internal part; LPGi, lateral paragigantocellular nucleus; LRt, lateral reticular nucleus; LRtSS, lateral reticular nucleus, subtrigeminal part; LSO, lateral superior olive; LVe, lateral vestibular nucleus; mcp, middle cerebellar peduncle; MD, mediodorsal thalamic nucleus; MdD, medullary reticular nucleus, dorsal part; MdV, medullary reticular nucleus, ventral part; MeS, mesencephalic trigeminal nucleus; Med, medial (fastigual) cerebellar nucleus; MGD, medial geniculate nucleus, dorsal part; MGV, medial geniculate nucleus, ventral part; MHb, medial habenular nucleus; mlf, medial longitudinal fasciculus; MM, medial mammillary nucleus, medial part; MnR, median raphe; MoS, motor trigeminal nucleus; MP, medial mammillary nucleus, posterior part; MPB, medial parabrachial nucleus; MSO, medial superior olive; mt, mammillothalamic tract; MVe, medial vestibular nucleus; n5, trigeminal nerve; n7, facial nerve; n8, vestibulocochlear nerve; Op, optic nerve layer of the superior colliculus; OT, nucleus of the optic tract; opt, optic tract; PS, peritrigeminal zone; P7, perifacial zone; PB, parabrachial nuclei; PBG, parabigeminal nucleus; PC, paracentral thalamic nucleus; pc, posterior commissure; PCRt, parvocellular reticular nucleus; PF, parafascicular thalamic nucleus; PH, posterior hypothalamic area; PMn, paramedian reticular nucleus; PMR, paramedian raphe nucleus; Pn, pontine nuclei; PnC, pontine reticular nucleus, caudal part; PnO, pontine reticular nucleus, oral part; PnV, pontine reticular nucleus, ventral part; PO, posterior thalamic nuclear group; PP, peripeduncular nucleus; PrS, principal sensory trigeminal nucleus; PrH, prepositus hypoglossal nucleus; PSol, parasolitary nucleus; PV, paraventricular thalamic nucleus; py, pyramidal tract; R, red nucleus; Re, reuniens thalamic nucleus; RMC, red nucleus, magnocellular part; RMg, raphe magnus nucleus; Ro, nucleus of Roller; Rob, raphe obscurus nucleus; RPa, raphe pallidus (postpyramidal raphe) nucleus; RPn, raphe pontis nucleus; Rt, reticular thalamic nucleus; RtTg, reticulotegmental nucleus of the pons; RVL, rostroventrolateral reticular nucleus; scp, superior cerebellar peduncle; SGe, supragenial nucleus; SM, nucleus of the stria medullaris; SNC, substantia nigra, compact part; SNR, substantia nigra, reticular part; Sol, nucleus of the solitary tract; sol, solitary tract; sp5, spinal trigeminal tract; SpSC, spinal trigeminal nucleus, caudal part; SpSI, spinal trigeminal nucleus, interpolar part; SpSO, spinal trigeminal nucleus, oral part; SpVe, spinal vestibular nucleus; STh, subthalamic nucleus; SuS, supratrigeminal nucleus; SubCA, subcoerulus nucleus, alpha part; SubCD, subcoerulus nucleus, dorsal part; SubCV, subcoerulus nucleus, ventral part; SuG, superficial gray layer of the superior colliculus; SUM, supramammillary nucleus; SuVe, superior vestibular nucleus; Tz, nucleus of the trapezoid body; ~3, third ventricle; ~4, fourth ventricle; VC, ventral cochlear nucleus; VCP, ventral cochlear nucleus, posterior part; VLG, ventral lateral geniculate nucleus; VLL, ventral nucleus of the lateral lemniscus; VM, ventromedial thalamic nucleus; VMH, ventromedial hypothalamic nucleus; VPL, ventral posterolateral thalamic nucleus; VPM, ventral posteromedial thalamic nucleus; VTA, ventral tegmental area; VTg, ventral tegmental nucleus; X, nucleus X; xscp, decussation of the superior cerebellar peduncle; ZI, zona incerta. 
Section Number
CGPn and CG had about l/2 the density of PnC and PnO; other surrounding nuclei including the tegmental nuclei, CNF, and DpMe had levels of binding generally similar to that of CG.
PO, STh, PC, and PV. It would be difficult to define other thalamic nuclei with binding significantly above background.
Binding within nuclei giving rise to diffuse projection systems, the raphe complex and LC, was generally low. Highest binding was in RMg, with a continuum of lower binding values in LC, Rob, DR, RPn, RPa, PMR, MnR, and finally IP, with less than 10% the binding seen in RMg.
The highest binding in the corpus quadrigemini was in CIC, with levels comparable to those of MS0 and LVE. This level is only moderate for the rostrocaudal level of the colliculi. Much lower levels of binding were seen in ECIC, 25%, and DCIC, 15%. In the superior colliculus, SuG had the highest levels of binding, about 80% of CIC, and DpG and OP each had about 60% of the levels seen in CIC.
White-matter areas had binding densities equal to or barely above background. In general, in white-matter areas with binding above background, the binding could be attributed to areas immediately adjacent to surrounding gray matter. This was the case in spite of the relatively greater increase in specific activity due to the greater quench correction factors applied to whitematter areas.
Discussion
Neither the cerebellar cortex, nor the deep cerebellar nuclei Med, Int, or Lat had 3H-strychnine binding above background. However, the precerebellar nuclei LRt and LPGi had moderate levels of binding, RtTg had about 70% fewer sites, IO and RMC had about 85% fewer sites, and R and Pn about 90% fewer sites.
Limbic areas had very low levels of binding. The VTA had the highest levels, but even this was very low. Levels barely above background were seen in LHb, MHb, and SM. Of some significance however, is the binding in the amygdala, which was the only telencephalic structure with specific binding.
The results presented in this paper define the quench-corrected 3-dimensional distribution of 3H-strychnine binding sites in the mouse CNS. Three-dimensional imaging techniques have been applied by others to autoradiographic data on the CNS (Hibbard and Hawkins, 1984; Stein et al., 1984; Davis et al., 1986) . The methods presented here for determining the quench-corrected 3-dimensional distribution of neurotransmitter receptors enable accurate quantification of autoradiographic data on the distribution of not only neurotransmitter receptors, but also other features that can be autoradiographically localized. These data do not invalidate the work being performed by the numerous investigators applying receptor autoradiography to questions concerning chemical organization, but rather point the way to potential increased usefulness of the technique. Diencephalic nuclei had very low levels of binding. Compa-
The biochemical (Graham et al., 198 1, 1983 ; Pfeiffer and rable very low levels were seen in VMH, LH, DA, and PH. Betz, 1981; Pfeiffer et al., 1982) and pharmacological (Young About l/2 these values were found in LM, MM, SUM, and DM, and Snyder, 1973, 1974a, b; Mackerer et al., 1977) characterand essentially background levels were seen in MP and Arc. In istics and regional distribution of 3H-strychnine binding (Young general, binding to thalamic nuclei was comparable to or even and Snyder, 1973; Zarbin et al., 198 1) indicate that this binding lower than that seen in the hypothalamus. The sole exception measures inhibitory postsynaptic glycine receptors. Strychnine is PF, which bound 2% times as much as the highest hypothadoes not label the recently described glycine binding site found lamic nucleus and 4 times the next highest thalamic nucleus. in rostra1 brain areas (Bristow et al., 1986) , which may be an Binding in PF was highly specific to this nucleus and characallosteric site on the postsynaptic NMDA class of glutamate teristically outlines fr. Nuclei with 4-5 times less binding include receptors (Johnson and Ascher, 1987) . There is a great deal of similarity in the distribution of 3H-strychnine binding between the mouse (Frostholm and Rotter, 1985) , rat (Zarbin et al., 198 l) , and human . The posterior-anterior gradient is equally strong and there is a very good agreement in the overall density of binding sites among different areas. Somatic motor and sensory areas have the highest density of binding and special motor and sensory areas have lower, but still high, densities. Visceral afferent and efferent nuclei contain moderate levels of binding. The majority of the reticular formation has high to moderate levels of binding, with some of the more peripheral reticular nuclei containing lower levels. The inferior and superior colliculi have low levels of binding. Densities in the diencephalon are generally very low, as are densities in the limbic areas. The finding of specific binding in the amygdala is unique among telencephalic structures. Likewise, no specific binding is seen in the cerebellum or whitematter areas of the CNS.
The distribution of 3H-strychnine binding sites correlates well with both biochemical and electrophysiological data on the distribution of the inhibitory glycine neurotransmitter system. It also provides biochemical support for the role of glycine-mediated inhibition in local sensory and motor processing as well as local integrative activities in the posterior CNS. Many of the functional implications of this distribution on a number of behaviors and strychnine toxicity have been discussed extensively (Zarbin et al., 198 1) . This discussion would be equally applicable to the mouse. The regional distribution of 3H-strychnine binding sites and the functional implications of this distribution could explain the hyperexcitability, tremor, toe walking gait, and prolonged righting reflex seen in the spastic and spastic-Albany mutant mice, 2 allelic single-locus mutations in the mouse that have 80-95% fewer glycine receptors than controls (White and Heller, 1982; White, 1985; Becker et al., 1986; White et al., 1987) . In addition, the distribution would predict abnormalities in audition and in visceral functions such as blood pressure and respiratory rate in these mutants. The basic techniques presented in this paper, registration with other receptor binding data and tissue boundary contour data, and pixel-by-pixel mathematical functions enable pixel-by-pixel analysis and comparisons between data contained on adjacent sections. These data can be used to correct for differential efficiency as done in this study, to compare different neurotransmitter systems such as glycine and GABA receptors, or to compare different aspects of the same system such as different receptor subtypes, uptake sites versus receptor sites, and so forth.
In this paper we have looked at the heterogeneity in binding in the anterior-posterior dimension; a similar amount of heterogeneity would be expected in the dorsal-ventral, and mediallateral planes. This analysis could be performed on the current database given the appropriate software. In many ways it would seem most appropriate to study heterogeneity in 3 dimensions simultaneously in order to determine distributions such as center weighted, peripheral, or patchy, all of which might be expected in neurotransmitter receptor localization material.
A number of technical questions are raised by the methods used in these studies. These questions relate to the optimal distance between serial sections used for the 3-dimensional re-200 300 400 500 600 700 800
fmoles/mg tissue constructions, the distance between isodensity contours in the 3-dimensional reconstructions, the amount of detail in the isodensity contours (i.e., the amount of smoothing), the similarity required between sections to permit intersection mathematical functions, the best way to adequately present the data, and many others. Although there are no definitive answers to any of these questions, the answer for any particular study must take into consideration the degree of anatomical resolution required by the specific questions being addressed, the section thickness, the resolution of the film, and the resolving power of the data acquisition instrument. Continued experimental experience with these variables will be required to define the optimal parameters. One conclusion from this and numerous other studies on neurotransmitter receptor localization is that it is very difficult to present even a fraction of the data generated in such a study. It is impossible to distill the detailed localization information present in an autoradiographic image into a list of numbers that conveys the complexity of the underlying data. The use of techniques employed in this paper, such as correcting for differential efficiency and presenting data for the entire region on a series of sections taken through the rostrocaudal extent of the region, helps to present a more accurate representation of the data, but really is not useful for conveying the complexity. Some sense of complexity can be seen from the section-by-section data and the pixel histograms, but even here most of the anatomical information that may be very important for many types of analyses is lost. The only way to avoid these problems, and present an accurate representation of the complexity, is to present the actual data. However, there is so much data that this becomes difficult. Perhaps future developments in electronic data storage and management and its availability for publication purposes will permit the dissemination of this type of information. Certainly such a system would be a tremendous asset for the investigator interested in very detailed information on an area under study.
